Alpha Tau Medical Ltd. (DRTSW) Stock Ticker
Market factors today
Unlock the full DRTSW picture
About Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.
DRTSW stock facts
| Ticker symbol | DRTSW |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market cap | $1.5B |
| CEO | Uzi Sofer |
| Employees | 112 |
| Headquarters | Jerusalem, JM, IL |
| IPO date | 2026-03-06 |
| Website | www.alphatau.com |
What you can see for DRTSW on Tickr
Live DRTSW price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the DRTSW report.
Rankings
FAQ
What is the ticker symbol for Alpha Tau Medical Ltd.?
The ticker symbol for Alpha Tau Medical Ltd. is DRTSW, listed on the NASDAQ.
What is DRTSW?
Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was…